Astronauts Tom Stafford and Wally Schirra delighted mission control with their rendition of the Christmas classic ...

Q3 Highlights: Oddity reported third-quarter revenue of $147.9 million, beating analyst estimates of $145.44 million, according to Benzinga Pro. The consumer tech company reported third-quarter ...

Oddity's sales and profits are growing at an impressive clip. Management sees further gain ahead. Shares of Oddity Tech (NASDAQ: ODD) rose on Thursday after the skincare specialist delivered ...

Oddity Tech (ODD) rallied in postmarket trading after topping estimates and reporting strong top-line growth with its third-quarter earnings report. Revenue was up 24% year over year to $148 million, ...

We got a first look at some footage from Project Hail Mary back in June, and Amazon MGM Studios has now released a full trailer for the highly-anticipated sci-fi drama, giving us a much better idea of ...

Oddity combines high growth, profitability, and a data-driven advantage, differentiating it from traditional beauty brands and creating a compelling investment case. ODD leverages machine learning and ...

Oddity Tech’s consensus analyst price target has eased slightly, moving from $73.20 to $70.27. Recent research reflects evolving views on the company’s outlook. While analysts continue to cite ...

Oddity Tech (ODD) came out with quarterly earnings of $0.4 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.32 per share a year ago. These figures ...

ODDITY Tech (NASDAQ:ODD) will release its quarterly earnings report on Wednesday, 2025-11-19. Here's a brief overview for investors ahead of the announcement. Analysts anticipate ODDITY Tech to report ...

Oddity Tech Ltd (ODD) reported robust third-quarter results for 2025, surpassing earnings and revenue forecasts. The company posted an earnings per share (EPS) of $0.40, exceeding the forecasted $0.35 ...

From beauty to biotech, Oddity’s new venture, Methodiq, uses advanced computer vision technology and custom products to address the less glamorous, yet most overlooked side of skincare: chronic skin ...